Etofamide
Chemical compound
- P01AC03 (WHO)
- In general: ℞ (Prescription only)
- 2,2-dichloro-N-(2-ethoxyethyl)-N- [4-(4-nitrophenoxy)benzyl]acetamide
- 25287-60-9 Y
- 65718
- 59142
- 03F36JH21U
- D07355 Y
- ChEMBL1788393
- DTXSID40179926
- Interactive image
- CCOCCN(CC1=CC=C(C=C1)OC2=CC=C(C=C2)[N+](=O)[O-])C(=O)C(Cl)Cl
InChI
- InChI=1S/C19H20Cl2N2O5/c1-2-27-12-11-22(19(24)18(20)21)13-14-3-7-16(8-4-14)28-17-9-5-15(6-10-17)23(25)26/h3-10,18H,2,11-13H2,1H3
- Key:QTRALMGDQMIVFF-UHFFFAOYSA-N
Etofamide (INN, also known as eticlordifene) is an antiprotozoal drug used in the treatment of amoebiasis.
Its effect against Giardia lamblia has been described as modest.[1]
References
- ^ Cedillo-Rivera R, Muñoz O (September 1992). "In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents". Journal of Medical Microbiology. 37 (3): 221–4. doi:10.1099/00222615-37-3-221. PMID 1518040.
- v
- t
- e
Tissue amebicides |
| ||||||
---|---|---|---|---|---|---|---|
Luminal amebicides |
| ||||||
Other/ungrouped |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e